table of content
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size: 2022 VS 2030
2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting (CINV) Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chemotherapy-Induced Nausea and Vomiting (CINV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.6.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Markets, 2022 & 2030
4.1.2 CINV
4.1.3 PONV
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2022 & 2030
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.3.2 US Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.3.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.3.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.4.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.3 France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.4 U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.5 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.6 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.7 Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.8 Benelux Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.5.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.4 South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.5 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.6 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.6.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.6.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.7.2 Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.3 Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.4 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.5 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
7 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.1.4 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.2.4 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 ProStrakan
7.3.1 ProStrakan Company Summary
7.3.2 ProStrakan Business Overview
7.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.3.4 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.3.5 ProStrakan Key News & Latest Developments
7.4 Helsinn Holding
7.4.1 Helsinn Holding Company Summary
7.4.2 Helsinn Holding Business Overview
7.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.4.4 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.4.5 Helsinn Holding Key News & Latest Developments
7.5 Mundipharma
7.5.1 Mundipharma Company Summary
7.5.2 Mundipharma Business Overview
7.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.5.4 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.5.5 Mundipharma Key News & Latest Developments
7.6 Qilu Pharma
7.6.1 Qilu Pharma Company Summary
7.6.2 Qilu Pharma Business Overview
7.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.6.4 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.6.5 Qilu Pharma Key News & Latest Developments
7.7 Teva
7.7.1 Teva Company Summary
7.7.2 Teva Business Overview
7.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.7.4 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.7.5 Teva Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.8.4 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Heron Therapeutics
7.9.1 Heron Therapeutics Company Summary
7.9.2 Heron Therapeutics Business Overview
7.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.9.4 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.9.5 Heron Therapeutics Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.10.4 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Business Overview
7.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.11.4 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.11.5 Mylan Key News & Latest Developments
7.12 Tesaro
7.12.1 Tesaro Company Summary
7.12.2 Tesaro Business Overview
7.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.12.4 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.12.5 Tesaro Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
